Glucose Metabolic Disorder After Transplantation
Is It Risky to Use Kidneys from CDC-Increased Risk Donors?
Countries' Donation Performance in Perspective
Intercellular Transfer of MHC and Immunological Molecules
Options for Immunologic Support of Renal Transplantation Through the HLA and Immunology Laboratories
CD4+CD25+ Regulatory T Cells in Transplantation
American Society of Transplantation Symposium on B Cells in Transplantation
Antigenic Disparity Impacts Outcome of Agonism but Not Blockade of Costimulatory Pathways in Experimental Transplant Models
Mechanism of NKT Cell-Mediated Transplant Tolerance
Induction of Anoikis Following Myoblast Transplantation into SCID Mouse Muscles Requires the Bit1 and FADD Pathways
Results of an International, Randomized Trial Comparing Glucose Metabolism Disorders and Outcome with Cyclosporine Versus Tacrolimus
Estimated Benefits of Transplantation of Kidneys from Donors at Increased Risk for HIV or Hepatitis C Infection
Effect of Population Aging on the International Organ Donation Rates and the Effectiveness of the Donation Process
Risk Factors for Urinary Complications After Renal Transplantation
Insurability of Living Organ Donors
Tubular Basement Membrane Immune Deposits in Association with BK Polyomavirus Nephropathy
Patient and Graft Survival Implications of Simultaneous Pancreas Kidney Transplantation From Old Donors
Early Withdrawal of Calcineurin Inhibitors and Rescue Immunosuppression with Sirolimus-Based Therapy in Renal Transplant Recipients with Moderate to Severe Renal Dysfunction
Brain Death Activates Donor Organs and Is Associated with a Worse I/R Injury After Liver Transplantation
Short Waitlist Time Does Not Adversely Impact Outcome Following Liver Transplantation for Hepatocellular Carcinoma
Hepatocellular Carcinoma Recurrence and Death Following Living and Deceased Donor Liver Transplantation
Once-Daily Tacrolimus Extended-Release Formulation
Tacrolimus Monotherapy Without Steroids After Liver Transplantation – A Prospective Randomized Double-Blinded Placebo-Controlled Trial
Changes in International Normalized Ratio (INR) and Model for Endstage Liver Disease (MELD) Based on Selection of Clinical Laboratory
Whole-Liver Graft Without the Retrohepatic Inferior Vena Cava for Sequential (Domino) Living Donor Liver Transplantation
Usefulness of PCR Strategies For Early Diagnosis of Chagas' Disease Reactivation and Treatment Follow-Up in Heart Transplantation
Human Ehrlichiosis in Transplant Recipients
Preemptive Therapy of EBV-Related Lymphoproliferative Disease after Pediatric Haploidentical Stem Cell Transplantation
Financial Implications of Pancreas Transplant Complications
High Expression of Tim-3 mRNA in Urinary Cells from Kidney Transplant Recipients with Acute Rejection
BK Virus Associated Renal Cell Carcinoma
A Mouse Model of Orthotopic Vascularized Aerated Lung Transplantation
Atlas of Organ Transplantation by A. Humar, A. J. Matas, W. D. Payne
Erratum
Erratum